Michelle A. Yu

Michelle A. Yu

Auto-generated profile, based on publicly available information

Michelle A. Yu

University of California

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
GOGuadalupe Ortiz-Muñoz
Guadalupe Ortiz-Muñoz
MYMichelle A. Yu
Michelle A. Yu
ELEmma Lefrançais
Emma Lefrançais
BMBeñat Mallavia
Beñat Mallavia
CVColin Valet
Colin Valet
MLMark R. Looney
Mark R. Looney
Cystic fibrosis (CF) lung disease is characterized by an inflammatory response that can lead to terminal respiratory failure. The cystic fibrosis transmembrane conductance regulator (CFTR) is mutated in CF, and we hypothesized that dysfunctional CFTR in platelets, which are key participants in immune responses, is a central determinant of CF inflammation. We found that deletion of CFTR in platelets produced exaggerated acute lung inflammation and platelet activation after intratracheal LPS or Pseudomonas aeruginosa challenge. CFTR loss of function in mouse or human platelets resulted in agonist-induced hyperactivation and increased calcium entry into platelets. Inhibition of the transient receptor potential cation channel 6 (TRPC6) reduced platelet activation and calcium flux, and reduced lung injury in CF mice after intratracheal LPS or Pseudomonas aeruginosa challenge. CF subjects receiving CFTR modulator therapy showed partial restoration of CFTR function in platelets, which may be a convenient approach to monitoring biological responses to CFTR modulators. We conclude that CFTR dysfunction in platelets produces aberrant TRPC6-dependent platelet activation, which is a major driver of CF lung inflammation and impaired bacterial clearance. Platelets and TRPC6 are what we believe to be novel therapeutic targets in the treatment of CF lung disease.

15 November 2019 in Journal of Bacteriology
Verified
Journal Article
Closed access
JQJiuxin Qu
Jiuxin Qu
NPNeha K Prasad
Neha K Prasad
MYMichelle A Yu
Michelle A Yu
SCShuyan Chen
Shuyan Chen
ALAmy Lyden
Amy Lyden
OROren S Rosenberg
Oren S Rosenberg
Antibiotic resistance is a growing threat to global health. To optimize the use of our existing antibiotics and identify new targets for future inhibitors, understanding the fundamental drivers of bacterial growth in the context of the host immune response is paramount. Historically, these genetic drivers have been difficult to manipulate precisely, as they are requisite for pathogen survival. Here, we provide the first application of Mobile-CRISPRi to study conditionally essential virulence genes in mouse models of lung infection through partial gene perturbation. We envision the use of Mobile-CRISPRi in future pathogenesis models and antibiotic target discovery efforts.

1 October 2011 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
MYMichelle A. Yu
Michelle A. Yu
TETsuyoshi Egawa
Tsuyoshi Egawa
KSKyoko Shinzawa-Itoh
Kyoko Shinzawa-Itoh
SYShinya Yoshikawa
Shinya Yoshikawa
SYSyun-Ru Yeh
Syun-Ru Yeh
GGGary J. Gerfen
Gary J. Gerfen

1 February 2012 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
MYMichelle A. Yu
Michelle A. Yu
TETsuyoshi Egawa
Tsuyoshi Egawa
KSKyoko Shinzawa-Itoh
Kyoko Shinzawa-Itoh
SYShinya Yoshikawa
Shinya Yoshikawa
VGVictor Guallar
Victor Guallar
GGGary J. Gerfen
Gary J. Gerfen

20 January 2023 in Science Advances
Verified
Journal Article
Closed access
JFJoel Finbloom
Joel Finbloom
PRPreethi Raghavan
Preethi Raghavan
MKMichael Kwon
Michael Kwon
BKBhushan N. Kharbikar
Bhushan N. Kharbikar
MYMichelle A. Yu
Michelle A. Yu
TDTejal A Desai
Tejal A Desai
Bacterial biofilm infections, particularly those of Pseudomonas aeruginosa (PA), have high rates of antimicrobial tolerance and are commonly found in chronic wound and cystic fibrosis lung infections. Combination therapeutics that act synergistically can overcome antimicrobial tolerance; however, the delivery of multiple therapeutics at relevant dosages remains a challenge. We therefore developed a nanoscale drug carrier for antimicrobial codelivery by combining approaches from polyelectrolyte nanocomplex (NC) formation and layer-by-layer electrostatic self-assembly. This strategy led to NC drug carriers loaded with tobramycin antibiotics and antimicrobial silver nanoparticles (AgTob-NCs). AgTob-NCs displayed synergistic enhancements in antimicrobial activity against both planktonic and biofilm PA cultures, with positively charged NCs outperforming negatively charged formulations. NCs were evaluated in mouse models of lung infection, leading to reduced bacterial burden and improved survival outcomes. This approach therefore shows promise for nanoscale therapeutic codelivery to treat recalcitrant bacterial infections.

1 April 2010 in Journal of Magnetic Resonance
Verified
Journal Article
Open access
MYMichelle A. Yu
Michelle A. Yu
TETsuyoshi Egawa
Tsuyoshi Egawa
SYSyun-Ru Yeh
Syun-Ru Yeh
DRDenis L. Rousseau
Denis L. Rousseau
GGGary J. Gerfen
Gary J. Gerfen
The reaction intermediates of reduced bovine Cytochrome c Oxidase (CcO) were trapped following its reaction with oxygen at 50 micros-6 ms by innovative freeze-quenching methods and studied by EPR. When the enzyme was reduced with either ascorbate or dithionite, distinct radicals were generated; X-band (9 GHz) and D-band (130 GHz) CW-EPR measurements support the assignments of these radicals to ascorbyl and sulfur dioxide anion radical (SO2(-.)), respectively. The X-band spectra show a linewidth of 12 G for the ascorbyl radical and 11 G for the SO2(-.) radical and an isotropic g-value of 2.005 for both species. The D-band spectra reveal clear distinctions in the g-tensors and powder patterns of the two species. The ascorbyl radical spectrum displays approximate axial symmetry with g-values of g(x)=2.0068, g(y)=2.0066, and g(z)=2.0023. The SO2(-.) radical has rhombic symmetry with g-values of g(x)=2.0089, g(y)=2.0052, and g(z)=2.0017. When the contributions from the ascorbyl and SO2(-.) radicals were removed, no protein-based radical on CcO could be identified in the EPR spectra.